{"id":44060,"date":"2022-05-18T14:01:26","date_gmt":"2022-05-18T12:01:26","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/renovorx-to-participate-in-upcoming-h-c-wainwright-global-investment-conference-in-may-2022\/"},"modified":"2022-05-18T14:01:26","modified_gmt":"2022-05-18T12:01:26","slug":"renovorx-to-participate-in-upcoming-h-c-wainwright-global-investment-conference-in-may-2022","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/renovorx-to-participate-in-upcoming-h-c-wainwright-global-investment-conference-in-may-2022\/","title":{"rendered":"RenovoRx to Participate in Upcoming H.C Wainwright Global Investment Conference in May 2022"},"content":{"rendered":"
\n

LOS ALTOS, Calif.–(BUSINESS WIRE)–RenovoRx, Inc. (\u201cRenovoRx\u201d or the \u201cCompany\u201d) (Nasdaq: RNXT), a biopharmaceutical company and innovator in targeted cancer therapy, today announced management\u2019s participation in the H.C. Wainwright Global Investment Conference on May 23-26, 2022 in Miami Beach, Florida.\n<\/p>\n

\nH.C. Wainwright Global Investment Conference
\n
<\/b>Format and Dates: Hybrid, May 23-26, 2022
\n
Location: Fountainebleau Miami Beach Hotel, Miami Beach, Florida
\n
Presenter: Shaun Bagai, CEO, to present on Tuesday, May 24th<\/sup> at 7:00 a.m. ET
\n
Webcast: https:\/\/journey.ct.events\/view\/5f614744-5362-43e8-8ef4-8cabc6ee5d0a<\/a>
Register: Visit the RenovoRx Website Events page<\/a>\n<\/p>\n

\nShaun Bagai, RenovoRx\u2019s CEO, will provide a Company update and will participate in one-on-one meetings with the investment community. Attendees include public companies, and institutional and private investors. To schedule a meeting, please reach out to your H.C. Wainwright representative or send an email to KCSA Strategic Communications at RenovoRx@KCSA.com<\/a>.\n<\/p>\n

\nA recording of this presentation will be posted to the RenovoRx Website Events<\/a> page when it becomes available.\n<\/p>\n

\nAbout RenovoRx, Inc.<\/b>\n<\/p>\n

\nRenovoRx is a clinical-stage biopharmaceutical company focused on fighting cancer through the localized treatment of difficult to treat tumors via its proprietary RenovoRx Trans-Arterial Micro-Perfusion (RenovoTAMP\u2122) therapy platform. RenovoTAMP utilizes approved chemotherapeutics with validated mechanisms of action and well-established safety and side effect profiles, with the goal of increasing their efficacy, improving their safety, and widening their therapeutic window. RenovoRx\u2019s lead product candidate, RenovoGem\u2122, is a combination of gemcitabine and our patented delivery system, RenovoCath\u00ae, and is regulated by the FDA as a novel oncology drug product to treat unresectable locally advanced pancreatic cancer (LAPC). RenovoGem is currently being studied in the Phase 3 TIGeR-PaC trial for the treatment of LAPC.\n<\/p>\n

\nRenovoRx\u2019s patent portfolio includes seven U.S. patents for its technology. RenovoRx has been granted Orphan Drug Designation for intra-arterial delivery of gemcitabine for the treatment of both pancreatic cancer and bile duct cancer.\n<\/p>\n

\nRenovoRx won the Drug Delivery Technology category of the Fierce Innovation Awards \u2013 Life Sciences Edition 2020 for its RenovoTAMP technology.\n<\/p>\n

\nLearn more by visiting the RenovoRx website<\/a> or following us on Facebook<\/a>, LinkedIn<\/a> and Twitter<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nCompany Contact:<\/b>
RenovoRx, Inc.
\n
Shaun R. Bagai, CEO
\n
Christopher J. Lehman, CFO\n<\/p>\n

\nInvestor Contact:<\/b>
KCSA Strategic Communications
\n
Valter Pinto or Jack Perkins
\n
T:212-896-1254
\n
renovorx@kcsa.com<\/a>\n<\/p>\n

\nMedia Contact:<\/b>
Knight Marketing Communications, Ltd.
\n
Kevin Knight
\n
T: 206-451-4823
\n
kknightpr@gmail.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

LOS ALTOS, Calif.–(BUSINESS WIRE)–RenovoRx, Inc. (\u201cRenovoRx\u201d or the \u201cCompany\u201d) (Nasdaq: RNXT), a biopharmaceutical company and innovator in targeted cancer therapy, today announced management\u2019s participation in the H.C. Wainwright Global Investment Conference on May 23-26, 2022 in Miami Beach, Florida. H.C. Wainwright Global Investment Conference Format and Dates: Hybrid, May 23-26, 2022 Location: Fountainebleau Miami Beach … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-44060","6":"format-standard","7":"category-industry"},"yoast_head":"\nRenovoRx to Participate in Upcoming H.C Wainwright Global Investment Conference in May 2022 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/renovorx-to-participate-in-upcoming-h-c-wainwright-global-investment-conference-in-may-2022\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"RenovoRx to Participate in Upcoming H.C Wainwright Global Investment Conference in May 2022 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"LOS ALTOS, Calif.–(BUSINESS WIRE)–RenovoRx, Inc. (\u201cRenovoRx\u201d or the \u201cCompany\u201d) (Nasdaq: RNXT), a biopharmaceutical company and innovator in targeted cancer therapy, today announced management\u2019s participation in the H.C. Wainwright Global Investment Conference on May 23-26, 2022 in Miami Beach, Florida. H.C. Wainwright Global Investment Conference Format and Dates: Hybrid, May 23-26, 2022 Location: Fountainebleau Miami Beach ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/renovorx-to-participate-in-upcoming-h-c-wainwright-global-investment-conference-in-may-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-05-18T12:01:26+00:00\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/renovorx-to-participate-in-upcoming-h-c-wainwright-global-investment-conference-in-may-2022\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/renovorx-to-participate-in-upcoming-h-c-wainwright-global-investment-conference-in-may-2022\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"RenovoRx to Participate in Upcoming H.C Wainwright Global Investment Conference in May 2022\",\"datePublished\":\"2022-05-18T12:01:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/renovorx-to-participate-in-upcoming-h-c-wainwright-global-investment-conference-in-may-2022\\\/\"},\"wordCount\":412,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/renovorx-to-participate-in-upcoming-h-c-wainwright-global-investment-conference-in-may-2022\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/renovorx-to-participate-in-upcoming-h-c-wainwright-global-investment-conference-in-may-2022\\\/\",\"name\":\"RenovoRx to Participate in Upcoming H.C Wainwright Global Investment Conference in May 2022 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"datePublished\":\"2022-05-18T12:01:26+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/renovorx-to-participate-in-upcoming-h-c-wainwright-global-investment-conference-in-may-2022\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/renovorx-to-participate-in-upcoming-h-c-wainwright-global-investment-conference-in-may-2022\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/renovorx-to-participate-in-upcoming-h-c-wainwright-global-investment-conference-in-may-2022\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"RenovoRx to Participate in Upcoming H.C Wainwright Global Investment Conference in May 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"RenovoRx to Participate in Upcoming H.C Wainwright Global Investment Conference in May 2022 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/renovorx-to-participate-in-upcoming-h-c-wainwright-global-investment-conference-in-may-2022\/","og_locale":"en_US","og_type":"article","og_title":"RenovoRx to Participate in Upcoming H.C Wainwright Global Investment Conference in May 2022 - Pharma Trend","og_description":"LOS ALTOS, Calif.–(BUSINESS WIRE)–RenovoRx, Inc. (\u201cRenovoRx\u201d or the \u201cCompany\u201d) (Nasdaq: RNXT), a biopharmaceutical company and innovator in targeted cancer therapy, today announced management\u2019s participation in the H.C. Wainwright Global Investment Conference on May 23-26, 2022 in Miami Beach, Florida. H.C. Wainwright Global Investment Conference Format and Dates: Hybrid, May 23-26, 2022 Location: Fountainebleau Miami Beach ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/renovorx-to-participate-in-upcoming-h-c-wainwright-global-investment-conference-in-may-2022\/","og_site_name":"Pharma Trend","article_published_time":"2022-05-18T12:01:26+00:00","author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/renovorx-to-participate-in-upcoming-h-c-wainwright-global-investment-conference-in-may-2022\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/renovorx-to-participate-in-upcoming-h-c-wainwright-global-investment-conference-in-may-2022\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"RenovoRx to Participate in Upcoming H.C Wainwright Global Investment Conference in May 2022","datePublished":"2022-05-18T12:01:26+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/renovorx-to-participate-in-upcoming-h-c-wainwright-global-investment-conference-in-may-2022\/"},"wordCount":412,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/renovorx-to-participate-in-upcoming-h-c-wainwright-global-investment-conference-in-may-2022\/","url":"https:\/\/pharma-trend.com\/en\/renovorx-to-participate-in-upcoming-h-c-wainwright-global-investment-conference-in-may-2022\/","name":"RenovoRx to Participate in Upcoming H.C Wainwright Global Investment Conference in May 2022 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"datePublished":"2022-05-18T12:01:26+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/renovorx-to-participate-in-upcoming-h-c-wainwright-global-investment-conference-in-may-2022\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/renovorx-to-participate-in-upcoming-h-c-wainwright-global-investment-conference-in-may-2022\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/renovorx-to-participate-in-upcoming-h-c-wainwright-global-investment-conference-in-may-2022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"RenovoRx to Participate in Upcoming H.C Wainwright Global Investment Conference in May 2022"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44060","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=44060"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44060\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=44060"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=44060"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=44060"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}